跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NEP-1
首页
药物
NEP-1
NEP-1
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
3-(1-[3-(1,3-Benzothiazol-6-yl)propylcarbamoyl]cycloalkyl)propanoic acid derivatives as NEP inhibitors
申请人: PFIZER
优先权: 2004
US
NEP INHIBITORS FOR TREATING DISEASES CHARACTERIZED BY ATRIAL ENLARGEMENT OR REMODELING
申请人: NOVARTIS AG
优先权: 2012
CN
EP
US
7 件公开
Processes
申请人: HOOK DAVID
优先权: 2008
CN
US
7 件公开
PROCESS FOR THE PREPARATION OF INTERMEDIATES FOR THE MANUFACTURE OF NEP INHIBITORS
申请人: NOVARTIS AG
优先权: 2010
CN
EP
US
WO
5 件公开
Process for the preparation of intermediates useful for the manufacture NEP inhibitors
申请人: HOOK DAVID
优先权: 2010
US
3 件公开
Intermediates of neutral endopeptidase inhibitors and preparation method thereof
申请人: HOOK DAVID
优先权: 2010
CN
US
4 件公开
Compounds with NEP/MP-inhibitory activity and uses thereof
申请人: SOLVAY PHARM GMBH
优先权: 2001
CN
US
2 件公开
Preparation method of Jiangxi ketene ester key synthetic raw material
申请人: DENG HUA
优先权: 2022
CN
药物
反馈